Thanks for calling <a href="http://mikesilverman.com/peace/index.php/kamedepipigq-ef0f.pdf#buzz">sciecurepharma.com</a>  The experimental drug, called alirocumab, is from apromising new class of injectable cholesterol fighters alsobeing developed by Amgen Inc and other drugmakers. Theywork by blocking a naturally occurring protein called PCSK9 andcould each garner annual sales of $3 billion or more, ifapproved, according to some industry analysts.